← Back to Search

Machine Learning + Peer Support for Substance Use Disorder

N/A
Recruiting
Led By James J Mahoney, Ph.D.
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily up to 5 years
Awards & highlights

Study Summary

This trial studies how substance cravings, behavior, and physical markers respond to wearable tech/questionnaires for people with substance use disorder. It'll look at how peer support affects outcomes.

Who is the study for?
This trial is for adults over 18 with substance use disorders who are currently or were previously treated at a WVU Medicine Clinic, or residents of sober living facilities. Participants must be able to consent and download the required health app and wearable device apps on their smart devices.Check my eligibility
What is being tested?
The study aims to predict relapse in individuals with substance use disorder using machine learning technology that analyzes data from wearables like Oura rings, smartwatches, and responses on the RNI Health app. It also tests if peer recovery interventions can prevent relapse when prompted by abnormal biomarkers.See study design
What are the potential side effects?
Since this trial involves monitoring through technology and peer support rather than medication, traditional side effects are not applicable. However, participants may experience privacy concerns or emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Balloon Analogue Risk Task
Changes in heart rate
Changes in heart rate variability
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PRSS interventionExperimental Treatment1 Intervention
Participants receiving PRSS intervention will be contacted by the PRSS who will be blinded (not knowing whether an alert was caused by data anomaly or a random generation), and will contact the participant by phone and assess the need for assistance. PRSS will follow-up with the participant to assist participant if needed (once after the initial alert and then a second follow-up).
Group II: Treatment as usualActive Control1 Intervention
Participants will receive standard of care treatment as usual and will receive no contact from a peer recover support specialist (PRSS intervention) when data anomalies are detected by machine learning algorithms.

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
176 Previous Clinical Trials
59,714 Total Patients Enrolled
James J Mahoney, Ph.D.Principal InvestigatorWest Virginia University Rockefeller Neuroscience Institute

Media Library

PRSS intervention Clinical Trial Eligibility Overview. Trial Name: NCT05976672 — N/A
Substance Use Disorder Research Study Groups: Treatment as usual, PRSS intervention
Substance Use Disorder Clinical Trial 2023: PRSS intervention Highlights & Side Effects. Trial Name: NCT05976672 — N/A
PRSS intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05976672 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities to participate in this experiment presently available?

"Affirmative, according to the data hosted on clinicaltrials.gov this medical trial is currently looking for participants. It was initially posted on April 27th 2023 and most recently edited on July 27th 2023. This study requires the recruitment of 500 patients across 1 site."

Answered by AI

How many participants are included in the research project?

"Affirmative. Clinicaltrials.gov demonstrates that this study, which went live on April 27th 2023, is actively seeking applicants. Approximately 500 patients will be sourced from a single medical centre."

Answered by AI
~333 spots leftby Apr 2028